Immune-related adverse events for patients with lung cancer-volume II

被引：0
|
作者：
Wang, Yusha [1 ,2 ]
Wang, Xia [3 ]
Zhan, Cheng [4 ]
Frey, Benjamin [5 ]
Gaipl, Udo S. [5 ]
Shi, Hubing [1 ,2 ]
Ma, Xuelei [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Biotherapy, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Biotherapy Res, Chengdu, Sichuan, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China
[5] Dept Radiat Oncol, Univ Klinikum Erlangen, Erlangen, Germany
来源：
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词：
immune-related adverse events (irAEs); immune checkpoint inhibitors (ICIs); Immunotherapy; lung cancer; editorial;
D O I：
10.3389/fonc.2023.1282394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Investigating biomarkers for immune-related adverse events following immune checkpoint inhibitor therapy in recurrent lung cancer patients
    Kudo, Yujin
    Matsubayashi, Jun
    Takahashi, Satoshi
    Hagiwara, Masaru
    Kakihana, Masatoshi
    Nagao, Toshitaka
    Ohira, Tatsuo
    Ikeda, Norihiko
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II
    Burnett, Deborah L.
    Barnet, Megan B.
    Moxon, Ania
    Tsang, Venessa
    Samaras, Katherine
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [33] Assessing the Relationship between Thrombosis and Immune-Related Adverse Events in Patients with Lung Cancer Treated with Immune Checkpoint Inhibitors
    Isaza, Daniela Arango
    O'Loughlin, Lauren
    Patell, Rushad
    Viray, Hollis
    Neuberg, Donna S.
    Dodge, Laura E.
    Rangachari, Deepa
    Asnani, Aarti
    Zwicker, Jeffrey, I
    Costa, Daniel
    BLOOD, 2022, 140 : 11372 - 11373
  • [34] Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis
    Wang, Donghui
    Chen, Cen
    Gu, Yanli
    Lu, Wanjun
    Zhan, Ping
    Liu, Hongbing
    Lv, Tangfeng
    Song, Yong
    Zhang, Fang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Immune-Related Adverse Events of Genitourinary Cancer Patients, a Retrospective Cohort Study
    Hunting, John C.
    Deyo, Logan
    Olson, Eric
    Faucheux, Andrew T.
    Price, Sarah N.
    Lycan Jr, Thomas W.
    CANCERS, 2024, 16 (17)
  • [36] Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy
    Ezponda Casajus, A.
    Calvo Imirizaldu, M.
    de Torres Tajes, J. P.
    Garcia-Baizan, A.
    Castanon Alvarez, E.
    Cano Rafart, D.
    Vivas Perez, I
    Bastarrika Aleman, G.
    RADIOLOGIA, 2020, 62 (02): : 131 - 138
  • [37] Immune-related adverse events and immunotherapy efficacy in patients with cancer: A retrospective study
    Prather, Lyndsey L.
    Ali, Atif
    Wang, Hannah
    Du, Wendy
    Chen, Nan
    Sheth, Aakash
    Sandulache, Vlad
    Sabichi, Anita Lyn
    Kemnade, Jan Ole
    Wang, Daniel Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] THYROID IMMUNE-RELATED ADVERSE EVENTS ARE ASSOCIATED WITH IMPROVED SURVIVAL IN CANCER PATIENTS
    Abdallah, Duaa
    Goldner, Whitney
    Johnosn, Jake
    Kotwal, Anupam
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (07) : 1584 - 1584
  • [39] Immune-Related Adverse Events: Pneumonitis
    Jain, Akash
    Shannon, Vickie R.
    Sheshadri, Ajay
    IMMUNOTHERAPY, 2ND EDITION, 2018, 995 : 131 - 149
  • [40] Management of immune-related adverse events
    Princk, Marika Henriette
    Pervan, Mascha
    Riedl, Jorg
    GYNAKOLOGIE, 2023, 56 (04): : 253 - 259
12345